WFA
AYTU icon

West Financial Advisors’s AYTU BioPharma AYTU Stock Holding History

West Financial Advisors’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$31 – 161
2024
Q1 		$31 Buy
+10
New +$29 ﹤0.01% 154

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

West Financial Advisors's AYTU Position: Q2 2024 in Review

West Financial Advisors sold out of AYTU BioPharma (AYTU) in Q2 2024, closing a stake of 10 shares — an estimated $31 sold.

West Financial Advisors first reported a position in AYTU in Q1 2024 and held it in 1 quarter. The position peaked at $31 in Q1 2024. 27 funds tracked by Wall St. Rank hold AYTU as of Q2 2024.

  • West Financial Advisors reported no remaining AYTU BioPharma position as of Q2 2024 after selling out during the quarter.
  • West Financial Advisors sold 10 AYTU BioPharma shares in Q2 2024, an estimated $31.
  • West Financial Advisors first reported a position in AYTU BioPharma in Q1 2024 and held it in 1 quarter.
  • West Financial Advisors's AYTU BioPharma position peaked at $31 in Q1 2024.
  • 27 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2024.

Based on West Financial Advisors's 13F filing for Q2 2024, filed 15 Jul 2024.